rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1990-3-21
|
pubmed:abstractText |
Malignant pericardial effusion and tamponade are rarely seen complications of epithelial ovarian cancer. With the use of multiagent chemotherapy these complications may be seen more frequently in the future. Therapy should be individualized, as long-term survival may be possible if the systemic manifestations of the cancer can be controlled.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0038-4348
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
83
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
241-2
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2305307-Carcinoma, Papillary,
pubmed-meshheading:2305307-Cardiac Tamponade,
pubmed-meshheading:2305307-Combined Modality Therapy,
pubmed-meshheading:2305307-Drainage,
pubmed-meshheading:2305307-Female,
pubmed-meshheading:2305307-Humans,
pubmed-meshheading:2305307-Middle Aged,
pubmed-meshheading:2305307-Ovarian Neoplasms,
pubmed-meshheading:2305307-Pericardial Effusion,
pubmed-meshheading:2305307-Prognosis
|
pubmed:year |
1990
|
pubmed:articleTitle |
Survival after malignant pericardial effusion and cardiac tamponade in advanced ovarian cancer.
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Tex.
|
pubmed:publicationType |
Journal Article,
Case Reports
|